Procter & Gamble Health Complete Financial Statements
PGHL • Review detailed financials to uncover trends, confirm thesis & journal trades
10 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Procter & Gamble Health (PGHL).
Downloads include all available records across all periods.
For market performance, see the
PGHL stock price today
.
Profitability Ratios
Net Profit Margin
24.76%
2025 data
EBITDA Margin
34.81%
2025 data
Operating Margin
34.00%
2025 data
Return on Assets
29.47%
2025 data
Return on Equity
43.58%
2025 data
Balance Sheet Ratios
Current Ratio
12.52
2025 data
Debt to Equity
1.48
2025 data
Equity Ratio
67.63%
2025 data
Asset Turnover
1.19
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
+37.7%
Year-over-Year
Net Profit Growth
+31.2%
Year-over-Year
EBITDA Growth
+31.0%
Year-over-Year
Expense Growth
+41.1%
Year-over-Year
Equity Growth
-0.2%
Year-over-Year
Operating Cash Flow Growth
-25.9%
Year-over-Year
Investing Cash Flow Growth
+242.9%
Year-over-Year
Financing Cash Flow Growth
+43.8%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,301 | 945 | 1,167 | 1,248 | 1,128 | 1,027 | 1,425 | 873 | 722 | 1,017 | 963 |
| Expenses | 869 | 616 | 845 | 905 | 847 | 763 | 1,041 | 701 | 621 | 877 | 856 |
| EBITDA | 431 | 329 | 322 | 343 | 281 | 264 | 384 | 173 | 101 | 140 | 107 |
| Operating Profit Margin % | 32.00% | 34.00% | 27.00% | 26.00% | 24.00% | 24.00% | 23.00% | 17.00% | 11.00% | 12.00% | 9.00% |
| Depreciation | 23 | 17 | 27 | 28 | 27 | 30 | 30 | 21 | 19 | 25 | 23 |
| Interest | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 408 | 312 | 273 | 314 | 253 | 233 | 355 | 158 | 99 | 115 | 83 |
| Tax | 103 | 77 | 72 | 85 | 61 | 57 | 101 | 56 | 38 | 36 | 30 |
| Net Profit | 307 | 234 | 201 | 230 | 193 | 177 | 254 | 102 | 61 | 79 | 54 |
| Earnings Per Share (₹) | 184.80 | 141.00 | 121.00 | 138.00 | 116.00 | 107.00 | 153.00 | 505.27 | 56.60 | 47.70 | 32.30 |
Related Pages for Procter & Gamble Health
Additional stock information and data for PGHL
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| Total Assets | 794 | 794 | 1,101 | 888 | 986 | 1,176 | 1,760 | 991 | 879 | 784 |
| Current Assets | 526 | 524 | 796 | 608 | 727 | 954 | 1,534 | 752 | 636 | 572 |
| Fixed Assets | 116 | 129 | 144 | 112 | 104 | 101 | 104 | 115 | 111 | 132 |
| Capital Work in Progress | 11 | 6 | 33 | 41 | 39 | 22 | 17 | 9 | 30 | 7 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 70 | 28 | 42 |
| Other Assets | 667 | 660 | 925 | 736 | 843 | 1,053 | 1,639 | 797 | 711 | 603 |
| LIABILITIES | ||||||||||
| Total Liabilities | 794 | 794 | 1,101 | 888 | 986 | 1,176 | 1,760 | 991 | 879 | 784 |
| Current Liabilities | 42 | 37 | 46 | 40 | 44 | 42 | 27 | 33 | 29 | 27 |
| Non-Current Liabilities | ||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||
| Total Equity | 537 | 538 | 751 | 617 | 704 | 906 | 1,540 | 733 | 664 | 592 |
| Share Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves & Surplus | 520 | 522 | 734 | 600 | 687 | 890 | 1,524 | 717 | 647 | 575 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 169 | 228 | 236 | 170 | 247 | 235 | -130 | 54 | 107 | 84 |
| Investing Activities | 10 | -7 | -22 | -26 | -32 | 165 | 1,270 | -48 | -75 | -68 |
| Financing Activities | -235 | -418 | -99 | -289 | -387 | -883 | -30 | -22 | -15 | -12 |
| Net Cash Flow | -57 | -197 | 116 | -145 | -172 | -483 | 1,109 | -16 | 17 | 4 |